Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

AddLife

198.5

 

SEK

 

+0.92 %

Less than 1K followers

ALIF B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus

AddLife operates in the medical technology industry and focuses on the development, manufacturing and distribution of medical equipment and laboratory products. The company's products are aimed at healthcare institutions and research laboratories. The business is global with a primary presence in Europe, North America and Asia. AddLife was founded in 2015 and is headquartered in Stockholm, Sweden.

Read more
Market cap
24.31B SEK
Turnover
84.02M SEK
Revenue
10.29B
EBIT %
7.01 %
P/E
96.36
Dividend yield-%
0.38 %
Financial calendar
15/7
2025

Interim report Q2'25

23/10
2025

Interim report Q3'25

4/2
2026

Annual report '25

All
Webcasts
Press releases
3rd party
ShowingAll content types
Regulatory press release6/2/2025, 6:23 AM

Finansinspektionen: Flaggningsmeddelande i AddLife AB

AddLife
Regulatory press release5/8/2025, 3:45 PM

Årsstämma i AddLife AB den 8 maj 2025

AddLife
Regulatory press release5/8/2025, 3:45 PM

Annual General Meeting of AddLife AB 8 May 2025

AddLife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/25/2025, 5:45 AM

Margin improvement continues, the debt level is reduced, and acquisition activity increases

AddLife
Regulatory press release4/25/2025, 5:45 AM

Marginalförbättringen fortsätter, skuldsättningen minskar och förvärvsaktiviteten ökar

AddLife
Regulatory press release4/4/2025, 7:00 AM

AddLifes årsredovisning för 2024 offentliggjord

AddLife
Regulatory press release4/4/2025, 7:00 AM

AddLife's Annual Report for 2024 is now published

AddLife
Press release4/1/2025, 1:00 PM

AddLife förvärvar Edge Medical Ltd

AddLife
Press release4/1/2025, 1:00 PM

AddLife acquires Edge Medical Ltd

AddLife
Regulatory press release3/27/2025, 10:00 AM

Notice to attend the Annual General Meeting of AddLife AB (publ)

AddLife
Regulatory press release3/27/2025, 10:00 AM

Kallelse till årsstämma i AddLife AB (publ)

AddLife
Third party research2/27/2025, 12:32 PM

Addlife: I god form - Analysguiden

Addlife ökade omsättningen med 11% under fjärde kvartalet 2024, organisk tillväxt exklusive valutapåverkan och förvärv ökade omsättningen med 9%. Bolagets EBITA för kvartalet uppgick till 346 MSEK (278) motsvarande en marginal på 12,3% (10,9%). Fortsatt...

AddLife
Press release2/27/2025, 12:25 PM

Analysguiden: ANALYS Addlife: I god form

AddLife
Regulatory press release2/5/2025, 6:45 AM

AddLife: Year-end Report 1 January - 31 December 2024

AddLife
Regulatory press release2/5/2025, 6:45 AM

AddLife: Bokslutskommuniké 1 januari - 31 december 2024

AddLife
Third party research12/16/2024, 7:31 AM

Addlife: Säsongsmässigt svagare kvartal - Analysguiden

Addlife ökade omsättningen med 1% (3% organiskt) till 2 344 MSEK under tredje kvartalet, jämfört med 2 319 MSEK samma period 2023. EBITA uppgick till 223 MSEK, motsvarande en marginal på 9,5% (10,5%). Både Labtech och Medtech växte organiskt, även om...

AddLife
Press release12/16/2024, 7:30 AM

Analysguiden: ANALYS Addlife: Säsongsmässigt svagare kvartal

AddLife
Regulatory press release11/21/2024, 12:19 PM

Finansinspektionen: Flaggningsmeddelande i AddLife AB

AddLife
Regulatory press release10/31/2024, 1:00 PM

Change in the number of shares and votes in AddLife AB

AddLife
Regulatory press release10/31/2024, 1:00 PM

Ändring av antalet aktier och röster i AddLife AB

AddLife
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team